|Articles|May 1, 2000

CME: Pediatrics and the Human Genome Project

A massive undertaking to determine the sequence of the several billion DNA building blocks that represent the human genome is almost complete. Pediatricians can look forward to new molecular tests for diagnosing inherited disorders in the near future. Novel therapies should follow.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

CME: Pediatrics and the Human Genome Project

Related Content

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

Weekly review: Mental health concerns, FDA approvals, and more

Jeffrey Temple, PhD, discusses new Surgeon General Advisory on screen time use in youth

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease